AI assistant
SURMODICS INC — Director's Dealing 2017
Jun 20, 2017
32845_dirs_2017-06-20_16f8763e-347e-41b0-aa79-e9b9a605efd7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2017-06-16
Reporting Person: Phillips Bryan K (SVP, Gen Counsel & Secretary)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-06-16 | Common Stock | S | 1226 | $24.8526 | Disposed | 29208 | Direct |
Footnotes
F1: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2017.
F2: Reflects the weighted average price of 1,226 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on June 16, 2017 with sale prices ranging from $24.75 to $24.95 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.